Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Carolina A. Rush"'
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/ea9415448cc94374bb23c28d29752761
Autor:
Simon Thebault, Hyunwoo Lee, Gauruv Bose, Daniel Tessier, Mohammad Abdoli, Marjorie Bowman, Jason Berard, Lisa Walker, Carolina A. Rush, Heather MacLean, Ronald A. Booth, Sridar Narayanan, Douglas L. Arnold, Vincent Tabard‐Cossa, Harold L. Atkins, Amit Bar‐Or, Mark S. Freedman
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 7, Iss 5, Pp 767-775 (2020)
Abstract Objective Accelerated brain volume loss has been noted following immunoablative autologous hematopoietic stem cell transplantation (IAHSCT) for multiple sclerosis. As with other MS treatments, this is often interpreted as ‘pseudoatrophy’
Externí odkaz:
https://doaj.org/article/a0f954f44c874eaaa3c50b3113801a58
Publikováno v:
Frontiers in Neuroscience, Vol 15 (2021)
Measurement of serum neurofilament light chain concentration (sNfL) promises to become a convenient, cost effective and meaningful adjunct for multiple sclerosis (MS) prognostication as well as monitoring disease activity in response to treatment. De
Externí odkaz:
https://doaj.org/article/51da2b3564044093ab2dd03207ddbbfb
Autor:
Harold L. Atkins, Daniel R. Tessier, Jason A. Berard, Gauruv Bose, Carolina A Rush, Mark S. Freedman, Hyun Woo Lee, Douglas L. Arnold, Simon Thebault, Heather MacLean, Lisa Walker, Amit Bar-Or, Ronald A. Booth, Mohammad Abdoli, Vincent Tabard-Cossa, Marjorie Bowman, Sridar Narayanan
Publikováno v:
Annals of Clinical and Translational Neurology
Annals of Clinical and Translational Neurology, Vol 7, Iss 5, Pp 767-775 (2020)
Annals of Clinical and Translational Neurology, Vol 7, Iss 5, Pp 767-775 (2020)
Objective Accelerated brain volume loss has been noted following immunoablative autologous hematopoietic stem cell transplantation (IAHSCT) for multiple sclerosis. As with other MS treatments, this is often interpreted as ‘pseudoatrophy’, related
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5ed2ca3ef5144589048dff74de4d4e4
https://doi.org/10.1002/acn3.51045
https://doi.org/10.1002/acn3.51045
Publikováno v:
Multiple sclerosis (Houndmills, Basingstoke, England). 27(2)
The most effective treatment at halting inflammation in patients with highly active multiple sclerosis (MS) is immune ablation followed by autologous hematopoietic stem cell transplantation (AHSCT). Better patient selection and supportive management,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6a8c4d273e0ee6d8801dee3e61f1bc5
https://pubmed.ncbi.nlm.nih.gov/32364422
https://pubmed.ncbi.nlm.nih.gov/32364422
Publikováno v:
Multiple Sclerosis and Related Disorders. 52:102945
Highly active MS may warrant higher efficacy treatments for disease control. However, these often confer more risk and have not been compared in head-to-head clinical trials, making relative efficacy and safety difficult to interpret. Alemtuzumab and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04ca95b4eaf3ccfdf361b7c83e83f30e
https://doi.org/10.1016/j.msard.2021.102945
https://doi.org/10.1016/j.msard.2021.102945
Autor:
Courtney Gardner, Heather MacLean, Mark S. Freedman, Carolina A Rush, Marjorie A. Bowman, Lisa Walker
Background: People with multiple sclerosis (MS) are at increased risk for cognitive impairment, mental health concerns, and psychosocial issues, which can negatively affect disease outcomes and quality of life. Current MS care guidelines recommend in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d7c89e664520e24f3f7f9c1586026e9
https://europepmc.org/articles/PMC6928579/
https://europepmc.org/articles/PMC6928579/
Publikováno v:
Nature Reviews Neurology. 11:379-389
Multiple sclerosis (MS) is a CNS disorder characterized by inflammation, demyelination and neurodegeneration, and is the most common cause of acquired nontraumatic neurological disability in young adults. The course of the disease varies between indi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cc8c493cf451b1a41738927a4ea232f
https://doi.org/10.1038/nrneurol.2015.85
https://doi.org/10.1038/nrneurol.2015.85
Autor:
Carolina A Rush, Mark S. Freedman
Publikováno v:
Continuum (Minneapolis, Minn.). 22(3)
Despite the efficacy of current therapies for relapsing forms of multiple sclerosis (MS), there remains a group of patients whose disease fails to respond and warrants a different approach to treatment. This article reviews this form of aggressive MS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::939d329f7239739e95c175499962860c
https://pubmed.ncbi.nlm.nih.gov/29851890
https://pubmed.ncbi.nlm.nih.gov/29851890
Publikováno v:
Cold Spring Harb Perspect Med
Multiple sclerosis (MS) is an autoimmune disorder that typically affects young people during their most productive years, causing irreversible damage and accumulation of disability. Treatments over time have had modest effects at completely controlli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a62385a3a1db02cdcf9d75a9ca6d815
https://doi.org/10.1101/cshperspect.a029082
https://doi.org/10.1101/cshperspect.a029082